{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:19:27Z","timestamp":1788542367333,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,1,15]],"date-time":"2018-01-15T00:00:00Z","timestamp":1515974400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s12094-018-1832-5","type":"journal-article","created":{"date-parts":[[2018,1,15]],"date-time":"2018-01-15T08:41:35Z","timestamp":1516005695000},"page":"1153-1160","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Pancreaticoduodenectomy for periampullary tumours: a review article based on Surveillance, End Results and Epidemiology (SEER) database"],"prefix":"10.1007","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2748-0011","authenticated-orcid":false,"given":"S. K.","family":"Kamarajah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,15]]},"reference":[{"issue":"3","key":"1832_CR1","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S0039-6109(05)70142-0","volume":"81","author":"JM Sarmiento","year":"2001","unstructured":"Sarmiento JM, Nagomey DM, Sarr MG, Farnell MB. Periampullary cancers: are there differences? Surg Clin North Am. 2001;81(3):543\u201355.","journal-title":"Surg Clin North Am"},{"issue":"7","key":"1832_CR2","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/jso.21374","volume":"100","author":"J Albores-Saavedra","year":"2009","unstructured":"Albores-Saavedra J, Schwartz AM, Batich K, Henson DE. Cancers of the ampulla of vater: demographics, morphology, and survival based on 5625 cases from the SEER program. J Surg Oncol. 2009;100(7):598\u2013605.","journal-title":"J Surg Oncol"},{"issue":"1","key":"1832_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7\u201330.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"1832_CR4","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.surg.2006.04.006","volume":"140","author":"TS Riall","year":"2006","unstructured":"Riall TS, Cameron JL, Lillemoe KD, Winter JM, Campbell KA, Hruban RH, et al. Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up. Surgery. 2006;140(5):764\u201372.","journal-title":"Surgery."},{"issue":"6","key":"1832_CR5","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1001\/archsurg.140.6.529","volume":"140","author":"KM Brown","year":"2005","unstructured":"Brown KM, Tompkins AJ, Yong S, Aranha GV, Shoup M. Pancreaticoduodenectomy is curative in the majority of patients with node-negative ampullary cancer. Arch Surg. 2005;140(6):529\u201332 (discussion 32\u20133).","journal-title":"Arch Surg"},{"issue":"4","key":"1832_CR6","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.jamcollsurg.2014.12.031","volume":"220","author":"JL Cameron","year":"2015","unstructured":"Cameron JL, He J. Two thousand consecutive pancreaticoduodenectomies. J Am Coll Surg. 2015;220(4):530\u20136.","journal-title":"J Am Coll Surg"},{"issue":"6","key":"1832_CR7","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1245\/s10434-011-2168-3","volume":"19","author":"GA Poultsides","year":"2012","unstructured":"Poultsides GA, Huang LC, Cameron JL, Tuli R, Lan L, Hruban RH, et al. Duodenal adenocarcinoma: clinicopathologic analysis and implications for treatment. Ann Surg Oncol. 2012;19(6):1928\u201335.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"1832_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/bjs.1800820137","volume":"82","author":"SR Bramhall","year":"1995","unstructured":"Bramhall SR, Allum WH, Jones AG, Allwood A, Cummins C, Neoptolemos JP. Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg. 1995;82(1):111\u20135.","journal-title":"Br J Surg"},{"issue":"10","key":"1832_CR9","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1002\/bjs.1800841010","volume":"84","author":"JP Neoptolemos","year":"1997","unstructured":"Neoptolemos JP, Russell RC, Bramhall S, Theis B. Low mortality following resection for pancreatic and periampullary tumours in 1026 patients: UK survey of specialist pancreatic units. UK Pancreatic Cancer Group. Br J Surg. 1997;84(10):1370\u20136.","journal-title":"Br J Surg"},{"issue":"9","key":"1832_CR10","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.gassur.2006.08.018","volume":"10","author":"JM Winter","year":"2006","unstructured":"Winter JM, Cameron JL, Campbell KA, Arnold MA, Chang DC, Coleman J, et al. 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg. 2006;10(9):1199\u2013210 (discussion 210\u20131).","journal-title":"J Gastrointest Surg."},{"issue":"5","key":"1832_CR11","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1097\/01.sla.0000216763.27673.97","volume":"243","author":"JM Winter","year":"2006","unstructured":"Winter JM, Cameron JL, Lillemoe KD, Campbell KA, Chang D, Riall TS, et al. Periampullary and Pancreatic Incidentaloma: a single Institution\u2019s experience with an increasingly common diagnosis. Ann Surg. 2006;243(5):673\u201383.","journal-title":"Ann Surg"},{"issue":"9293","key":"1832_CR12","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1016\/S0140-6736(01)06651-X","volume":"358","author":"JP Neoptolemos","year":"2001","unstructured":"Neoptolemos JP, Dunn JA, Stocken DD, Almond J, Link K, Beger H, et al. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet. 2001;358(9293):1576\u201385.","journal-title":"Lancet"},{"issue":"2","key":"1832_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1001\/jama.2012.7352","volume":"308","author":"JP Neoptolemos","year":"2012","unstructured":"Neoptolemos JP, Moore MJ, Cox TF, Valle JW, Palmer DH, McDonald AC, et al. Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. JAMA. 2012;308(2):147\u201356.","journal-title":"JAMA"},{"issue":"10073","key":"1832_CR14","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S0140-6736(16)32409-6","volume":"389","author":"JP Neoptolemos","year":"2017","unstructured":"Neoptolemos JP, Palmer DH, Ghaneh P, Psarelli EE, Valle JW, Halloran CM, et al. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet. 2017;389(10073):1011\u201324.","journal-title":"Lancet"},{"issue":"2","key":"1832_CR15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/sim.4780030207","volume":"3","author":"FE Harrell Jr","year":"1984","unstructured":"Harrell FE Jr, Lee KL, Califf RM, Pryor DB, Rosati RA. Regression modelling strategies for improved prognostic prediction. Stat Med. 1984;3(2):143\u201352.","journal-title":"Stat Med"},{"issue":"4","key":"1832_CR16","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1245\/s10434-009-0883-9","volume":"17","author":"I Hatzaras","year":"2010","unstructured":"Hatzaras I, George N, Muscarella P, Melvin WS, Ellison EC, Bloomston M. Predictors of survival in periampullary cancers following pancreaticoduodenectomy. Ann Surg Oncol. 2010;17(4):991\u20137.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"1832_CR17","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s00428-006-0255-9","volume":"449","author":"G Perrone","year":"2006","unstructured":"Perrone G, Santini D, Zagami M, Vincenzi B, Verzi A, Morini S, et al. COX-2 expression of ampullary carcinoma: correlation with different histotypes and clinicopathological parameters. Virchows Arch. 2006;449(3):334\u201340.","journal-title":"Virchows Arch"},{"issue":"5","key":"1832_CR18","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1097\/PAS.0b013e3181983ef7","volume":"33","author":"P Ruemmele","year":"2009","unstructured":"Ruemmele P, Dietmaier W, Terracciano L, Tornillo L, Bataille F, Kaiser A, et al. Histopathologic features and microsatellite instability of cancers of the papilla of vater and their precursor lesions. Am J Surg Pathol. 2009;33(5):691\u2013704.","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"1832_CR19","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00534-004-0898-3","volume":"11","author":"HP Fischer","year":"2004","unstructured":"Fischer HP, Zhou H. Pathogenesis of carcinoma of the papilla of Vater. J Hepatobiliary Pancreat Surg. 2004;11(5):301\u20139.","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"1832_CR20","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/1471-2407-8-170","volume":"8","author":"A Westgaard","year":"2008","unstructured":"Westgaard A, Tafjord S, Farstad IN, Cvancarova M, Eide TJ, Mathisen O, et al. Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma. BMC Cancer. 2008;8:170.","journal-title":"BMC Cancer."},{"issue":"1","key":"1832_CR21","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1001\/jamasurg.2016.3466","volume":"152","author":"JL Williams","year":"2017","unstructured":"Williams JL, Chan CK, Toste PA, Elliott IA, Vasquez CR, Sunjaya DB, et al. Association of histopathologic phenotype of periampullary adenocarcinomas with survival. JAMA Surg. 2017;152(1):82\u20138.","journal-title":"JAMA Surg."},{"issue":"3","key":"1832_CR22","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.amjsurg.2008.11.010","volume":"197","author":"MG Hurtuk","year":"2009","unstructured":"Hurtuk MG, Hughes C, Shoup M, Aranha GV. Does lymph node ratio impact survival in resected periampullary malignancies? Am J Surg. 2009;197(3):348\u201352.","journal-title":"Am J Surg"},{"issue":"4","key":"1832_CR23","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.hpb.2015.11.008","volume":"18","author":"BV Dasari","year":"2016","unstructured":"Dasari BV, Roberts KJ, Hodson J, Stevens L, Smith AM, Hubscher SG, et al. A model to predict survival following pancreaticoduodenectomy for malignancy based on tumour site, stage and lymph node ratio. HPB (Oxford). 2016;18(4):332\u20138.","journal-title":"HPB (Oxford)."},{"issue":"1","key":"1832_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/SLA.0b013e31817b6609","volume":"248","author":"MH Roest van","year":"2008","unstructured":"van Roest MH, Gouw AS, Peeters PM, Porte RJ, Slooff MJ, Fidler V, et al. Results of pancreaticoduodenectomy in patients with periampullary adenocarcinoma: perineural growth more important prognostic factor than tumour localization. Ann Surg. 2008;248(1):97\u2013103.","journal-title":"Ann Surg"},{"issue":"6","key":"1832_CR25","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1097\/00000658-200112000-00007","volume":"234","author":"JP Neoptolemos","year":"2001","unstructured":"Neoptolemos JP, Stocken DD, Dunn JA, Almond J, Beger HG, Pederzoli P, et al. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and\/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg. 2001;234(6):758\u201368.","journal-title":"Ann Surg"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-018-1832-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-018-1832-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-018-1832-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T19:57:37Z","timestamp":1547495857000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-018-1832-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,15]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["1832"],"URL":"https:\/\/doi.org\/10.1007\/s12094-018-1832-5","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,15]]},"assertion":[{"value":"15 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author declare that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study used an American Cancer registry (SEER) involving human participants and were in accordance with the ethical standards of the institution.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study, formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}